4.2 SURPASS-2 trial comparison of tirzepatide and semaglutide The SURPASS-2 trial, comprising 1,879 patients with type 2 diabetes, compared once-weekly tirzepatide (5 mg, 10 mg, 15 mg) with semaglutide 1 mg over a 40-week period
Its benefits include enhanced fat loss, improved insulin sensitivity, increased endurance, and potential anti-aging effects
The theory suggests these peptides may influence gene expression through epigenetic mechanisms, though the precise molecular interactions remain an area of ongoing investigation
When used under medical guidance, its a powerful supplement with wide-ranging health and cosmetic benefits
And as we've seen in the clinic now with the work that's been done, we're seeing things about addiction, even gambling, alcohol, drugs, I mean neuropsychiatric impact, it's pretty profound
Free Express Shipping parameters tier at $250